Hematologic Cancer

These guidelines and other documents provide advice for different types of hematologic cancer: non-Hodgkin lymphoma, leukemia, multiple myeloma, Hodgkin lymphoma, myelodysplastic syndrome (MDS) and myelofibrosis.

CAR T-cell Therapy Enrolment

Displaying Guidelines

14 Items

Extra-corporeal Photopheresis in the Management of Graft-Versus-Host Disease in Patients who Have Received Allogeneic Blood or Bone Marrow Transplants: Recommendations

Document Status: Current
ID: SCT 5

Aug 2013

First-Line Therapy, Autologous Stem Cell Transplantation, and Post-Transplant Maintenance in the Management of Patients Newly Diagnosed with Mantle Cell Lymphoma

Document Status: Current
ID: RR SCT-9
Version: N/A

Jun 2020

Management of Cardiovascular Risk Factors after Stem Cell Transplant

Document Status: Current
Version: 1

Apr 2019

Optimal Therapy for Patients Diagnosed with Multiple Myeloma and the Role of High-Dose Chemotherapy and Stem Cell Support

Document Status: Education and Information
ID: 6-6 Version 2
Version: 2

Jan 2012

Plerixafor for Autologous Hematopoietic Stem Cell Mobilization and Transplantation for Patients in Ontario

Document Status: Current
ID: SCT-7

Sep 2015

Screening for Secondary Solid Malignancies after Stem Cell Transplant

Document Status: Current
Version: 2

Mar 2022

Stem Cell Transplantation in Adults

Document Status: Archived
ID: SCT

Jan 2009

Stem Cell Transplantation in Lymphoma

Document Status: Archived
ID: SCT 4

Dec 2012

Stem Cell Transplantation in Multiple Myeloma

Document Status: In-Review
ID: SCT 1

Mar 2012

Stem Cell Transplantation in Myelodysplastic Syndromes and Acute Myeloid Leukemia

Document Status: In-Review
ID: SCT 3

Mar 2012

Stem Cell Transplantation in Primary Systemic Amyloidosis

Document Status: Current
ID: SCT-2
Version: 2

Nov 2019

Stem Cell Transplantation in the Treatment of Acute Lymphoblastic Leukemia: Recommendations

Document Status: In-Review
ID: SCT 6

Feb 2016